{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-1995-S-0039\" sorted by posted_date descending", "rows": [["FDA-1995-S-0039-0321", "FDA", "FDA-1995-S-0039", "Attachment 1 - Shah, et al., An Open Clinical Pilot Study to Evaluate the Safety and Efficacy of Natto Kinaseas an Add-on Oral Fibrinolytic Agent Tolow Molecular Weight Heparin & Anti-Plateletsin Acute Ischeamic Stroke\" re NDI 631, Nattolife/Nattokinase Enzyme from Zytech Biotech PVT LTD", "Supporting & Related Material", "Background Material", "2014-02-28T05:00:00Z", 2014, 2, null, null, "2016-08-15T20:52:33Z", null, 0, 0, "0900006480c36026"], ["FDA-1995-S-0039-0309", "FDA", "FDA-1995-S-0039", "NDI 674, Conifer Green Needle Complex CGNC from Solagran", "Other", "75 Day PreMarket Notification", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2016-09-30T14:24:47Z", null, 0, 0, "0900006480ec536b"], ["FDA-1995-S-0039-0312", "FDA", "FDA-1995-S-0039", "NDI 679, DHA-EPA Algal Oil from  Martek Biosciences Corporation", "Other", "75 Day PreMarket Notification", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2016-09-30T14:24:50Z", null, 0, 0, "0900006480ec8b58"], ["FDA-1995-S-0039-0311", "FDA", "FDA-1995-S-0039", "NDI 677 Amizate from Zymetch", "Other", "75 Day PreMarket Notification", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2016-09-30T14:24:49Z", null, 0, 0, "0900006480ec5aa6"], ["FDA-1995-S-0039-0310", "FDA", "FDA-1995-S-0039", "NDI 675, Sun Chlorella Agaricus from Sun Chlorella", "Other", "75 Day PreMarket Notification", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2016-09-30T14:24:48Z", null, 0, 0, "0900006480ec53ea"], ["FDA-1995-S-0039-0313", "FDA", "FDA-1995-S-0039", "Report 680 Hitex SAS (Miliaskin)", "Other", "Report", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2016-09-30T14:24:50Z", null, 0, 0, "0900006480ec8b68"], ["FDA-1995-S-0039-0315", "FDA", "FDA-1995-S-0039", "NDI 715, Ajuga Reptans Cell Culture Extracts from RB Istituto di Ricerche Biotecnologiche S.p.A", "Other", "75 Day PreMarket Notification", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2016-09-30T14:24:54Z", null, 0, 0, "0900006480fa1816"], ["FDA-1995-S-0039-0314", "FDA", "FDA-1995-S-0039", "NDI 681, Benfotiamine from Yonezawa Hamari Chemicals, Ltd", "Other", "75 Day PreMarket Notification", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2016-09-30T14:24:54Z", null, 0, 0, "0900006480ec8b89"], ["FDA-1995-S-0039-0317", "FDA", "FDA-1995-S-0039", "Attachments - Healthcare Professional Tab, Reseveratol re NDI 583,  Resveratrol from Ceres Living, Inc.", "Supporting & Related Material", "Background Material", "2014-02-27T05:00:00Z", 2014, 2, null, null, "2016-09-30T14:24:57Z", null, 0, 0, "0900006480ae77c3"], ["FDA-1995-S-0039-0319", "FDA", "FDA-1995-S-0039", "NDI 671,  7-Methylxanthine from AVEC Eye Center, LLC", "Other", "75 Day PreMarket Notification", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2016-09-30T14:25:00Z", null, 0, 0, "0900006480c47768"], ["FDA-1995-S-0039-0316", "FDA", "FDA-1995-S-0039", "NDI 716, GD Antrodia Camphorata from Golden Biotechnology Corporation", "Other", "75 Day PreMarket Notification", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2016-09-30T14:24:56Z", null, 0, 0, "0900006480fa1db0"], ["FDA-1995-S-0039-0318", "FDA", "FDA-1995-S-0039", "NDI 639 - Lumi Vida from DSM Food Specialities", "Other", "Report", "2014-02-27T05:00:00Z", 2014, 2, "2014-02-27T05:00:00Z", null, "2016-09-30T14:24:57Z", null, 0, 0, "0900006480b0e792"], ["FDA-1995-S-0039-0308", "FDA", "FDA-1995-S-0039", "FDA/CFSAN Response to General Nutrition Corporation - Supplement", "Other", "Supplement (SUP)", "2013-10-18T04:00:00Z", 2013, 10, "2013-10-18T04:00:00Z", null, "2016-09-30T14:24:47Z", null, 0, 0, "090000648055c502"], ["FDA-1995-S-0039-0304", "FDA", "FDA-1995-S-0039", "Report from FDA/CFSAN", "Other", "Report", "2012-09-23T04:00:00Z", 2012, 9, "2012-09-23T04:00:00Z", null, "2016-09-30T14:24:45Z", null, 0, 0, "090000648055c329"], ["FDA-1995-S-0039-0299", "FDA", "FDA-1995-S-0039", "Report from FDA/CFSAN", "Other", "Report", "2012-09-23T04:00:00Z", 2012, 9, "2012-09-23T04:00:00Z", null, "2016-09-30T14:24:43Z", null, 0, 0, "090000648055c312"], ["FDA-1995-S-0039-0307", "FDA", "FDA-1995-S-0039", "Attachment \"References\" Report from FDA/CFSAN", "Supporting & Related Material", "Report", "2012-09-23T04:00:00Z", 2012, 9, null, null, "2016-09-30T14:24:46Z", null, 0, 0, "090000648055c33a"], ["FDA-1995-S-0039-0296", "FDA", "FDA-1995-S-0039", "References 1 through 16 re NDI 589, 3b Androsterone from Proprietary Wellness", "Supporting & Related Material", "Background Material", "2012-07-23T04:00:00Z", 2012, 7, null, null, "2016-09-30T14:24:40Z", null, 0, 0, "0900006480a3efbc"], ["FDA-1995-S-0039-0298", "FDA", "FDA-1995-S-0039", "Mitsibushi Gas Chemical Company (Pyrroloquinoline Quinone Disodium Salt) Report 417 - Amended Report re FDA-1995-S-0039-0141", "Other", "Amendment", "2012-07-23T04:00:00Z", 2012, 7, null, null, "2016-09-30T14:24:43Z", null, 0, 0, "09000064807649bd"], ["FDA-1995-S-0039-0297", "FDA", "FDA-1995-S-0039", "Mitsibushi Gas Chemical Company (Pyrroloquinoline Quinone Disodium Salt) Report 417 - Report", "Other", "Report", "2012-07-23T04:00:00Z", 2012, 7, "2012-07-23T04:00:00Z", null, "2016-09-30T14:24:42Z", null, 0, 0, "0900006480560f26"], ["FDA-1995-S-0039-0293", "FDA", "FDA-1995-S-0039", "NDI 636, Extrafolate [6(R,S)-5-Methyltetrahydrofolic Acid, Calcium Salt from Gnosis S.P.A.", "Other", "75 Day PreMarket Notification", "2012-07-19T04:00:00Z", 2012, 7, null, null, "2016-09-30T14:24:35Z", null, 0, 0, "0900006480b0bc32"], ["FDA-1995-S-0039-0295", "FDA", "FDA-1995-S-0039", "NDI 638,  Marine Aminos of Pink Murex [Phyllonotus Erythrostomus] from Gold Leaf Sustainable", "Other", "75 Day PreMarket Notification", "2012-07-19T04:00:00Z", 2012, 7, "2012-07-19T04:00:00Z", null, "2016-09-30T14:24:39Z", null, 0, 0, "0900006480b0e705"], ["FDA-1995-S-0039-0294", "FDA", "FDA-1995-S-0039", "NDI 637, Extrafolate-S [6(S)-5-Methyltetrahydrofolic Acid, Calcium Salt] from Gnosis S.p.A.", "Other", "75 Day PreMarket Notification", "2012-07-19T04:00:00Z", 2012, 7, null, null, "2016-09-30T14:24:37Z", null, 0, 0, "0900006480b0cae1"], ["FDA-1995-S-0039-0292", "FDA", "FDA-1995-S-0039", "NDI 635, Geranti Bio-Ge Yeast from Gerenti Pharm Ltd", "Other", "75 Day PreMarket Notification", "2012-03-23T04:00:00Z", 2012, 3, "2012-03-23T04:00:00Z", null, "2016-09-30T14:24:34Z", null, 0, 0, "0900006480b0bab3"], ["FDA-1995-S-0039-0290", "FDA", "FDA-1995-S-0039", "NDI 632, Puresta Oil from YamahaMotor Co., LTD", "Other", "Report", "2012-03-23T04:00:00Z", 2012, 3, "2012-03-23T04:00:00Z", null, "2016-09-30T14:24:33Z", null, 0, 0, "0900006480b0a55d"], ["FDA-1995-S-0039-0291", "FDA", "FDA-1995-S-0039", "NDI 634, Horse Bone Extract from Branch Corporation Finance-Investment-Construction", "Other", "75 Day PreMarket Notification", "2012-03-23T04:00:00Z", 2012, 3, "2012-03-23T04:00:00Z", null, "2016-09-30T14:24:33Z", null, 0, 0, "0900006480b0b8dd"], ["FDA-1995-S-0039-0288", "FDA", "FDA-1995-S-0039", "Report 394 Amendment NDI 444 PHX Partners, LLC (Formerly PHX Health Solutions, Inc.)", "Other", "Report", "2012-03-22T04:00:00Z", 2012, 3, "2012-03-22T04:00:00Z", null, "2016-09-30T14:24:32Z", null, 0, 0, "09000064805609b6"], ["FDA-1995-S-0039-0287", "FDA", "FDA-1995-S-0039", "Report 393 Amendment NDI 443 PHX Partners, LLC (Formerly PHX Health Solutions, Inc.)", "Other", "Report", "2012-03-22T04:00:00Z", 2012, 3, "2012-03-22T04:00:00Z", null, "2016-09-30T14:24:31Z", null, 0, 0, "09000064805609b3"], ["FDA-1995-S-0039-0289", "FDA", "FDA-1995-S-0039", "Report 395 Amendment NDI 445 PHX Partners, LLC (Formerly PHX Health Solutions, Inc.)", "Other", "Report", "2012-03-22T04:00:00Z", 2012, 3, "2012-03-22T04:00:00Z", null, "2016-09-30T14:24:32Z", null, 0, 0, "09000064805609b8"], ["FDA-1995-S-0039-0286", "FDA", "FDA-1995-S-0039", "NDI 631, Nattolife/Nattokinase Enzyme from Zytech Biotech PVT LTD", "Other", "75 Day PreMarket Notification", "2012-03-19T04:00:00Z", 2012, 3, "2012-03-19T04:00:00Z", null, "2016-09-30T14:24:30Z", null, 0, 0, "0900006480c36025"], ["FDA-1995-S-0039-0278", "FDA", "FDA-1995-S-0039", "NDI 618, Sea Buckthorn Berry Juice from Meaningful Food Company", "Other", "75 Day PreMarket Notification", "2012-03-05T05:00:00Z", 2012, 3, "2012-03-05T05:00:00Z", null, "2016-09-30T14:24:20Z", null, 0, 0, "0900006480fcefc4"], ["FDA-1995-S-0039-0280", "FDA", "FDA-1995-S-0039", "NDI 623, Riboceine D-Ribose-L-Cysteine from Max International, LLC.", "Other", "75 Day PreMarket Notification", "2012-03-05T05:00:00Z", 2012, 3, "2012-03-05T05:00:00Z", null, "2016-09-30T14:24:25Z", null, 0, 0, "0900006480c08317"], ["FDA-1995-S-0039-0281", "FDA", "FDA-1995-S-0039", "NDI 624, Hydrolyzed Lignin from AVVA Pharmaceuticals AG", "Other", "75 Day PreMarket Notification", "2012-03-05T05:00:00Z", 2012, 3, "2012-03-05T05:00:00Z", null, "2018-11-30T20:28:08Z", null, 0, 0, "0900006480c1afd8"], ["FDA-1995-S-0039-0284", "FDA", "FDA-1995-S-0039", "NDI 629, Fulvic Acid from Miyamonte U.S.A., Inc", "Other", "75 Day PreMarket Notification", "2012-03-05T05:00:00Z", 2012, 3, "2012-03-05T05:00:00Z", null, "2016-09-30T14:24:29Z", null, 0, 0, "0900006480c1b0d5"], ["FDA-1995-S-0039-0283", "FDA", "FDA-1995-S-0039", "NDI 626, Lipowheat Oil from Hitex SAS", "Other", "75 Day PreMarket Notification", "2012-03-05T05:00:00Z", 2012, 3, "2012-03-05T05:00:00Z", null, "2016-09-30T14:24:28Z", null, 0, 0, "0900006480c1b0b6"], ["FDA-1995-S-0039-0282", "FDA", "FDA-1995-S-0039", "NDI 625, Obestilin from Sabinsa Corporation", "Other", "75 Day PreMarket Notification", "2012-03-05T05:00:00Z", 2012, 3, "2012-03-05T05:00:00Z", null, "2016-09-30T14:24:28Z", null, 0, 0, "0900006480c1b04e"], ["FDA-1995-S-0039-0285", "FDA", "FDA-1995-S-0039", "NDI 630, Mulberry Leaf Powder from Ray Farm Corporation", "Other", "75 Day PreMarket Notification", "2012-03-05T05:00:00Z", 2012, 3, "2012-03-05T05:00:00Z", null, "2016-09-30T14:24:29Z", null, 0, 0, "0900006480c1b0d6"], ["FDA-1995-S-0039-0279", "FDA", "FDA-1995-S-0039", "NDI 621, Fernblock from Industrial Farmaceutica Cantabria, S.A.", "Other", "75 Day PreMarket Notification", "2012-03-05T05:00:00Z", 2012, 3, "2012-03-05T05:00:00Z", null, "2016-09-30T14:24:24Z", null, 0, 0, "0900006480c08a3a"], ["FDA-1995-S-0039-0275", "FDA", "FDA-1995-S-0039", "Report 614 - Capterin from SanRx Pharmaceuticals  re NDI 611", "Other", "75 Day PreMarket Notification", "2012-03-02T05:00:00Z", 2012, 3, "2012-03-02T05:00:00Z", null, "2016-09-30T14:24:10Z", null, 0, 0, "0900006480ab7e4d"], ["FDA-1995-S-0039-0276", "FDA", "FDA-1995-S-0039", "NDI 615, Calcium Formate from Nephro Tech LLC", "Other", "75 Day PreMarket Notification", "2012-03-02T05:00:00Z", 2012, 3, "2012-03-02T05:00:00Z", null, "2016-09-30T14:24:15Z", null, 0, 0, "0900006480ab88b7"], ["FDA-1995-S-0039-0277", "FDA", "FDA-1995-S-0039", "NDI 616, Antrodia Cinnamomea from  MoTech Corporation", "Other", "75 Day PreMarket Notification", "2012-03-02T05:00:00Z", 2012, 3, "2012-03-02T05:00:00Z", null, "2016-09-30T14:24:19Z", null, 0, 0, "0900006480af05ab"], ["FDA-1995-S-0039-0272", "FDA", "FDA-1995-S-0039", "NDI 610 - AsrraGrin from Nuliv Science USA, Inc.", "Other", "75 Day PreMarket Notification", "2012-01-23T05:00:00Z", 2012, 1, "2012-01-23T05:00:00Z", null, "2016-09-30T14:24:02Z", null, 0, 0, "0900006480aad124"], ["FDA-1995-S-0039-0271", "FDA", "FDA-1995-S-0039", "NDI 609 -  Sonova 400 from Arcadia Biosciences, Inc.", "Other", "75 Day PreMarket Notification", "2012-01-23T05:00:00Z", 2012, 1, "2012-01-23T05:00:00Z", null, "2016-09-30T14:24:00Z", null, 0, 0, "0900006480aa9eaa"], ["FDA-1995-S-0039-0274", "FDA", "FDA-1995-S-0039", "NDI 613, SelenoForce from Sabinsa Corporation", "Other", "75 Day PreMarket Notification", "2012-01-23T05:00:00Z", 2012, 1, "2012-01-23T05:00:00Z", null, "2016-09-30T14:24:04Z", null, 0, 0, "0900006480ab317a"], ["FDA-1995-S-0039-0273", "FDA", "FDA-1995-S-0039", "NDI 612, Cissus Quadrangularis from Gateway Health Alliances, Inc.", "Other", "75 Day PreMarket Notification", "2012-01-23T05:00:00Z", 2012, 1, "2012-01-23T05:00:00Z", null, "2016-09-30T14:24:02Z", null, 0, 0, "0900006480aad125"], ["FDA-1995-S-0039-0265", "FDA", "FDA-1995-S-0039", "Attachment X -Joh et al, Clinical Result of the Intestinal Remedy (Biothree(r) Containing Three Live Bacteria Species for Bacterial Diarhea, Progress in Medicine Vol.13 (1983) re NDI 603, Bio-Three H Powder from Josifa International, Inc.", "Supporting & Related Material", "Background Material", "2012-01-18T05:00:00Z", 2012, 1, null, null, "2016-08-15T18:54:23Z", null, 0, 0, "0900006480f990d0"], ["FDA-1995-S-0039-0267", "FDA", "FDA-1995-S-0039", "NDI 606, Triclisia subcordata Oliv., Anuolu from Cornelius Babsanya-Craig", "Other", "75 Day PreMarket Notification", "2012-01-18T05:00:00Z", 2012, 1, "2012-01-18T05:00:00Z", null, "2016-09-30T14:23:58Z", null, 0, 0, "0900006480aa9a26"], ["FDA-1995-S-0039-0269", "FDA", "FDA-1995-S-0039", "Literature and References, Exhibits V-Z re NDI 607- NDI 584 Amendment - Antistax Red Vine Leaf Extract from Boehringer Ingelhheim Pharmaceuticals, Inc.", "Supporting & Related Material", "Background Material", "2012-01-18T05:00:00Z", 2012, 1, null, null, "2016-08-15T20:05:35Z", null, 0, 0, "0900006480aa9bff"], ["FDA-1995-S-0039-0264", "FDA", "FDA-1995-S-0039", "NDI 591, D-Ribose-L-Cysteine, Riboceine from Max International, LLC,", "Other", "75 Day PreMarket Notification", "2012-01-18T05:00:00Z", 2012, 1, "2012-01-18T05:00:00Z", null, "2016-09-30T14:23:57Z", null, 0, 0, "0900006480a3f3c5"], ["FDA-1995-S-0039-0266", "FDA", "FDA-1995-S-0039", "NDI 605, Sesame Peptide KM-20 from Uniglobe Kisco, Inc.", "Other", "75 Day PreMarket Notification", "2012-01-18T05:00:00Z", 2012, 1, "2012-01-18T05:00:00Z", null, "2016-09-30T14:23:58Z", null, 0, 0, "0900006480aa87e1"], ["FDA-1995-S-0039-0270", "FDA", "FDA-1995-S-0039", "NDI 608 - Lactobacillus Paracasei GM080 from GenMont Biotech, Inc.", "Other", "75 Day PreMarket Notification", "2012-01-18T05:00:00Z", 2012, 1, "2012-01-18T05:00:00Z", null, "2016-09-30T14:23:59Z", null, 0, 0, "0900006480b08de1"], ["FDA-1995-S-0039-0268", "FDA", "FDA-1995-S-0039", "NDI 607 NDI 584 Amendment - Boehringer Ingelhheim Pharmaceuticals, Inc. (Antistax Red Vine Leaf Extract)", "Other", "75 Day PreMarket Notification", "2012-01-18T05:00:00Z", 2012, 1, "2012-01-18T05:00:00Z", null, "2016-09-30T14:23:59Z", null, 0, 0, "0900006480aa9bcd"], ["FDA-1995-S-0039-0245", "FDA", "FDA-1995-S-0039", "References Cover Page - re NDI 587 - Androsta-1,4,6-triene-3,17-dione  from Proprietary Wellness", "Supporting & Related Material", "Background Material", "2012-01-17T05:00:00Z", 2012, 1, null, null, "2016-09-30T14:23:43Z", null, 0, 0, "0900006480a2bd3e"], ["FDA-1995-S-0039-0255", "FDA", "FDA-1995-S-0039", "NDI 597, Milkweed Seed Oil (MSO) from Natural Fibers Corporation", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:52Z", null, 0, 0, "0900006480a59a3a"], ["FDA-1995-S-0039-0246", "FDA", "FDA-1995-S-0039", "NDI 592 -  Androst-4-ene03,16,17-trione from Proprietary Wellness", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:47Z", null, 0, 0, "0900006480a408a1"], ["FDA-1995-S-0039-0260", "FDA", "FDA-1995-S-0039", "NDI 603, Bio-Three H Powder from Josifa International, Inc.", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:55Z", null, 0, 0, "0900006480a91b4a"], ["FDA-1995-S-0039-0247", "FDA", "FDA-1995-S-0039", "Cited References - re NDI 592 -  Androst-4-ene03,16,17-trione from Proprietary Wellness) (Part 1 of 3)", "Supporting & Related Material", "Background Material", "2012-01-17T05:00:00Z", 2012, 1, null, null, "2016-08-12T16:11:27Z", null, 0, 0, "0900006480a41168"], ["FDA-1995-S-0039-0261", "FDA", "FDA-1995-S-0039", "Attachment V - Nomura, et al, Probiotics Reduce Infectious Complications After Pancreaticoduodenectomy, Hepato-Gastroenterology Vol.54 (2007) re NDI 603, Bio-Three H Powder from Josifa International, Inc.", "Supporting & Related Material", "Background Material", "2012-01-17T05:00:00Z", 2012, 1, null, null, "2016-08-15T18:49:26Z", null, 0, 0, "0900006480aa55d1"], ["FDA-1995-S-0039-0254", "FDA", "FDA-1995-S-0039", "NDI 596,  NDI 596,  Homotaurine from Ovos Natural Health Inc from Ovos Natural Health Inc", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:51Z", null, 0, 0, "0900006480a7d6c8"], ["FDA-1995-S-0039-0262", "FDA", "FDA-1995-S-0039", "NDI 604,  Adrenosterone from Propietary Wellness", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:56Z", null, 0, 0, "0900006480aa6855"], ["FDA-1995-S-0039-0253", "FDA", "FDA-1995-S-0039", "Reference 1 - Hall et al, Recent Progress in the Consideration of Flavoring Ingredients Under the Food Additives Amendment, III.  GRAS Substances re NDI 595 -  Linalool Oil from Hanader Corporation", "Supporting & Related Material", "Background Material", "2012-01-17T05:00:00Z", 2012, 1, null, null, "2016-08-12T21:06:05Z", null, 0, 0, "0900006480a526bd"], ["FDA-1995-S-0039-0256", "FDA", "FDA-1995-S-0039", "NDI 598, Aka-shoma Extract Powder from BHN Co., Ltd", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:52Z", null, 0, 0, "0900006480a59a3b"], ["FDA-1995-S-0039-0259", "FDA", "FDA-1995-S-0039", "NDI 602,  Femblock from Industrial Farmaceutica Cantabria, S.A", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:54Z", null, 0, 0, "0900006480a913ba"], ["FDA-1995-S-0039-0258", "FDA", "FDA-1995-S-0039", "NDI 600, Corbicula Fluminea from Motech Corporation", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:54Z", null, 0, 0, "0900006480a8e405"], ["FDA-1995-S-0039-0250", "FDA", "FDA-1995-S-0039", "Amendment re NDI 594 - AlgaeCal from AlgaeCal, Inc.", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:49Z", null, 0, 0, "0900006480a51ea1"], ["FDA-1995-S-0039-0263", "FDA", "FDA-1995-S-0039", "Attachment 1 - Mayer et al., Seasonal Changes in and Effect of Castration/Androgen Replacement on the Plasma Levels of Five Androgens in the Male Three-Spined Stickleback, Gasterosteus Aculeatus L, General And Comparative Endocrinology Vol.17 (1990) re NDI 604 - Adrenosterone from Propietary Wellness", "Supporting & Related Material", "Background Material", "2012-01-17T05:00:00Z", 2012, 1, null, null, "2016-08-12T20:10:57Z", null, 0, 0, "0900006480aa6965"], ["FDA-1995-S-0039-0252", "FDA", "FDA-1995-S-0039", "NDI 595 -  Linalool Oil from Hanader Corporation", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:51Z", null, 0, 0, "0900006480a526bc"], ["FDA-1995-S-0039-0251", "FDA", "FDA-1995-S-0039", "Attachment 3 - Adey, et al., Phymatolithon Calcareum (Pallas) - re Amendment NDI 594 - AlgaeCal from AlgaeCal, Inc.", "Supporting & Related Material", "Background Material", "2012-01-17T05:00:00Z", 2012, 1, null, null, "2016-08-12T21:02:52Z", null, 0, 0, "0900006480a52075"], ["FDA-1995-S-0039-0257", "FDA", "FDA-1995-S-0039", "NDI 599, Niu Zhang Zhi Mycelia\nPowder, Essence of Antrodia Cinnamomea Capsules from Motech Corporation", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:53Z", null, 0, 0, "0900006480a59c58"], ["FDA-1995-S-0039-0249", "FDA", "FDA-1995-S-0039", "NDI 594 - AlgaeCal from AlgaeCal, Inc.", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:48Z", null, 0, 0, "0900006480a51ea0"], ["FDA-1995-S-0039-0248", "FDA", "FDA-1995-S-0039", "NDI 593 - Solubilized Eggshell Membrane from  Biova LLC", "Other", "75 Day PreMarket Notification", "2012-01-17T05:00:00Z", 2012, 1, "2012-01-17T05:00:00Z", null, "2016-09-30T14:23:48Z", null, 0, 0, "0900006480a51e9f"], ["FDA-1995-S-0039-0242", "FDA", "FDA-1995-S-0039", "Exhibit B - Reference -1 re NDI 590 - (Diosmin) Exhibits A and B from Exquim S.A.", "Supporting & Related Material", "Background Material", "2012-01-12T05:00:00Z", 2012, 1, null, null, "2016-09-21T20:54:34Z", null, 0, 0, "0900006480a7cac8"], ["FDA-1995-S-0039-0243", "FDA", "FDA-1995-S-0039", "Exhibit C Cited References 1 - 7  re NDI 590 - (Diosmin) Exhibits A and B from Exquim S.A.", "Supporting & Related Material", "Background Material", "2012-01-12T05:00:00Z", 2012, 1, null, null, "2016-08-11T19:54:38Z", null, 0, 0, "0900006480a7cb53"], ["FDA-1995-S-0039-0244", "FDA", "FDA-1995-S-0039", "Exhibit C - Reference 8 - Evaluation of the Health Aspects of Hesperidin, Naringin, and Citrus Bioflavonoid Extracts as Food Ingredients re Exhibit C Cited References 1 - 7  re NDI 590 - (Diosmin) Exhibits A and B from Exquim S.A.", "Supporting & Related Material", "Background Material", "2012-01-12T05:00:00Z", 2012, 1, null, null, "2016-09-30T14:23:43Z", null, 0, 0, "0900006480a7d613"], ["FDA-1995-S-0039-0241", "FDA", "FDA-1995-S-0039", "NDI 590 - (Diosmin) Exhibits A and B from Exquim S.A.", "Other", "75 Day PreMarket Notification", "2011-02-10T05:00:00Z", 2011, 2, "2011-02-10T05:00:00Z", null, "2016-09-30T14:23:42Z", null, 0, 0, "0900006480a7ca0b"], ["FDA-1995-S-0039-0238", "FDA", "FDA-1995-S-0039", "Report 416 - T. J. Panorama, Inc., (Nucleic Acid Supplement Capsules, AMP, CMP, GMP,UMP, and RNA)", "Other", "RPT-Report", "2010-10-06T04:00:00Z", 2010, 10, "2010-10-06T04:00:00Z", null, "2016-09-30T14:23:41Z", null, 0, 0, "0900006480560f17"], ["FDA-1995-S-0039-0239", "FDA", "FDA-1995-S-0039", "PanGenomics, Inc. (PG102, Actinidia Arguta) Report 164 - Report", "Other", "Report", "2010-10-06T04:00:00Z", 2010, 10, "2010-10-06T04:00:00Z", null, "2016-09-30T14:23:41Z", null, 0, 0, "090000648055ca0c"], ["FDA-1995-S-0039-0240", "FDA", "FDA-1995-S-0039", "Report 214 - Perrigo Company (Isopropoxy Isoflavone [Ipriflavone])", "Other", "RPT-Report (outside of agency unless indicated)", "2010-10-06T04:00:00Z", 2010, 10, "2010-10-06T04:00:00Z", null, "2016-09-30T14:23:42Z", null, 0, 0, "090000648055cd12"], ["FDA-1995-S-0039-0237", "FDA", "FDA-1995-S-0039", "NDI 583,  Resveratrol from Ceres Living, Inc.", "Other", "75 Day PreMarket Notification", "2010-05-05T04:00:00Z", 2010, 5, "2010-05-05T04:00:00Z", null, "2016-09-30T14:23:40Z", null, 0, 0, "0900006480ae77c1"], ["FDA-1995-S-0039-0235", "FDA", "FDA-1995-S-0039", "NDI 588, 3a Androsterone from Proprietary Wellness", "Other", "75 Day PreMarket Notification", "2010-03-01T05:00:00Z", 2010, 3, "2010-03-01T05:00:00Z", null, "2016-09-30T14:23:39Z", null, 0, 0, "0900006480a30fd0"], ["FDA-1995-S-0039-0236", "FDA", "FDA-1995-S-0039", "NDI 589, 3b Androsterone from Proprietary Wellness", "Other", "75 Day PreMarket Notification", "2010-03-01T05:00:00Z", 2010, 3, null, null, "2016-09-30T14:23:40Z", null, 0, 0, "0900006480a3efbb"], ["FDA-1995-S-0039-0234", "FDA", "FDA-1995-S-0039", "Letter from Onbix Corporation to FDA, October 21, 2008 re NDI 550 - NPL-X", "Other", "Letter(s)", "2010-01-10T05:00:00Z", 2010, 1, "2010-01-10T05:00:00Z", null, "2016-09-30T14:23:39Z", null, 0, 0, "0900006480a7894b"], ["FDA-1995-S-0039-0227", "FDA", "FDA-1995-S-0039", "Appendix L - \"Toxicology Consultant's Report: Consultants Resume,\" (Darcy Perkins, Ph.D)  - re NDI 586 - Oxaloacetic Acid from Terra Biological LLC", "Supporting & Related Material", "Background Material", "2009-12-09T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:37Z", null, 0, 0, "0900006480a2fdd3"], ["FDA-1995-S-0039-0224", "FDA", "FDA-1995-S-0039", "NDI 586 -  Oxaloacetic Acid from Terra Biological LLC", "Other", "75 Day PreMarket Notification", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2016-09-30T14:23:36Z", null, 0, 0, "0900006480a2eb6f"], ["FDA-1995-S-0039-0228", "FDA", "FDA-1995-S-0039", "Appendix A/Attachment A-4 (Redacted) - re NDI 586 - Oxaloacetic Acid from Terra Biological LLC", "Supporting & Related Material", "Background Material", "2009-12-09T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:37Z", null, 0, 0, "0900006480a2ff1a"], ["FDA-1995-S-0039-0233", "FDA", "FDA-1995-S-0039", "Letter from  FDA/CFSAN to Shannon Minerals Ltd.  re NDI 305 -  Extract of Garcinia Cambogia (Burren Spring Trim)", "Other", "Supplement (SUP)", "2009-12-09T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:38Z", null, 0, 0, "0900006480a6272c"], ["FDA-1995-S-0039-0230", "FDA", "FDA-1995-S-0039", "NDI 587 - Androsta-1,4,6-triene-3,17-dione  from Proprietary Wellness", "Other", "75 Day PreMarket Notification", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2016-09-30T14:23:37Z", null, 0, 0, "0900006480a2bc6d"], ["FDA-1995-S-0039-0232", "FDA", "FDA-1995-S-0039", "Letter from  FDA/CFSAN to Shannon Minerals Ltd.  re NDI 304 - Extract of Garcinia Cambogia (Coolwater Trim)", "Other", "Supplement (SUP)", "2009-12-09T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:38Z", null, 0, 0, "0900006480a6272b"], ["FDA-1995-S-0039-0226", "FDA", "FDA-1995-S-0039", "Appendices E-J (Redacted in its Entirety) - re NDI 586 -  Oxaloacetic Acid from Terra Biological LLC", "Supporting & Related Material", "Background Material", "2009-12-09T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:36Z", null, 0, 0, "0900006480a2fd96"], ["FDA-1995-S-0039-0231", "FDA", "FDA-1995-S-0039", "Reference 34 - Demonstration of 1,4,6-Androstatriene-3,17-Dione (ATD, CAS Registry No.633-35-2) in the Urine of an Untreated Boar\"References Cover Page - re References Cover Page re NDI 587 - Androsta-1,4,6-triene-3,17-dione  from Proprietary Wellness", "Supporting & Related Material", "Background Material", "2009-12-09T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:38Z", null, 0, 0, "0900006480a2be1b"], ["FDA-1995-S-0039-0225", "FDA", "FDA-1995-S-0039", "Appendices A-C and Attachment A-1,2 (Redacted in it Entirety) - re NDI 586 -  Oxaloacetic Acid from Terra Biological LLC.", "Supporting & Related Material", "Background Material", "2009-12-09T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:36Z", null, 0, 0, "0900006480a2eb71"], ["FDA-1995-S-0039-0229", "FDA", "FDA-1995-S-0039", "Attachment 13 - \"Greer, et al, An AMPK-FOXO Pathway Mediates the Extension of Lifespan Included by a Novel Method of Dietary Restriction In C. Elegans\"  - re NDI 586 - Oxaloacetic Acid from Terra Biological LLC", "Supporting & Related Material", "Background Material", "2009-12-09T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:37Z", null, 0, 0, "0900006480a309f6"], ["FDA-1995-S-0039-0223", "FDA", "FDA-1995-S-0039", "NDI 585 -  Blessed Seed from Nature Therapy Corporation", "Other", "75 Day PreMarket Notification", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2016-09-30T14:23:36Z", null, 0, 0, "0900006480a2a0df"], ["FDA-1995-S-0039-0212", "FDA", "FDA-1995-S-0039", "Appendix A - \"Background and History of Use\" - [Report 304 - Shannon Minerals Ltd. - Extract of Garcinia Cambogia (Coolwater Trim 75 Day Pre-Market Notification)]", "Supporting & Related Material", "RPT-Report (Supporting and Related Material)", "2009-12-04T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:32Z", null, 0, 0, "090000648055eebc"], ["FDA-1995-S-0039-0210", "FDA", "FDA-1995-S-0039", "Section 4 - \"History of Use/ Safety Evidence\" - [Report 304 - Shannon Minerals Ltd. - Extract of Garcinia Cambogia (Coolwater Trim 75 Day Pre-Market Notification)]", "Supporting & Related Material", "RPT-Report (Supporting and Related Material)", "2009-12-04T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:31Z", null, 0, 0, "090000648055eee5"], ["FDA-1995-S-0039-0221", "FDA", "FDA-1995-S-0039", "Section 4 - \"History of Use/Safety Evidence\" - [Report 305 - Shannon Minerals, Ltd. - Extract of Garcinia Cambogia (Burren Spring Trim 75 Day Pre-Market Notification)]", "Supporting & Related Material", "RPT-Report (Supporting and Related Material)", "2009-12-04T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:34Z", null, 0, 0, "090000648055ef01"], ["FDA-1995-S-0039-0213", "FDA", "FDA-1995-S-0039", "Appendix A - \"Lewis, et al., Research Paper; (-)-Hydroxycitric Acid The Principal Acid in the Fruits of Garcinia Cambogia Desr.\" - [Report 304 - Shannon Minerals Ltd. - Extract of Garcinia Cambogia (Coolwater Trim 75 Day Pre-Market Notification)", "Supporting & Related Material", "RPT-Report (Supporting and Related Material)", "2009-12-04T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:32Z", null, 0, 0, "090000648055eedc"], ["FDA-1995-S-0039-0209", "FDA", "FDA-1995-S-0039", "Section 3 - \"Description of the Products Containg Extract of Garcinia Cambogia, (-)-HCA\" - [Report 304 - Shannon Minerals Ltd. - Extract of Garcinia Cambogia (Coolwater Trim 75 Day Pre-Market Notification)]", "Supporting & Related Material", "RPT-Report (Supporting and Related Material)", "2009-12-04T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:31Z", null, 0, 0, "090000648055eeed"], ["FDA-1995-S-0039-0219", "FDA", "FDA-1995-S-0039", "Section 2 - \"Name and Identity of New Dietary Ingredient\" - [Report 305 - Shannon Minerals, Ltd. - Extract of Garcinia Cambogia (Burren Spring Trim 75 Day Pre-Market Notification)]", "Supporting & Related Material", "RPT-Report (Supporting and Related Material)", "2009-12-04T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:34Z", null, 0, 0, "090000648055eefc"], ["FDA-1995-S-0039-0203", "FDA", "FDA-1995-S-0039", "FDA/CFSAN Letter to Shannon Minerals Ltd - [Report 304 - Shannon Minerals Ltd. - Extract of Garcinia Cambogia (Coolwater Trim 75 Day Pre-Market Notification)", "Supporting & Related Material", "RPT-Report (Supporting and Related Material)", "2009-12-04T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:29Z", null, 0, 0, "090000648055eedf"], ["FDA-1995-S-0039-0220", "FDA", "FDA-1995-S-0039", "Section 3 - \"Description of the Products Containing Extract of Garcinia Cambogia, (-)-HCA\" - [Report 305 - Shannon Minerals, Ltd. - Extract of Garcinia Cambogia (Burren Spring Trim 75 Day Pre-Market Notification)]", "Supporting & Related Material", "RPT-Report (Supporting and Related Material)", "2009-12-04T05:00:00Z", 2009, 12, null, null, "2016-09-30T14:23:34Z", null, 0, 0, "090000648055eeff"]], "truncated": false, "filtered_table_rows_count": 320, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-1995-S-0039"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039", "results": [{"value": "FDA", "label": "FDA", "count": 320, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1995-S-0039", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039", "results": [{"value": "Other", "label": "Other", "count": 234, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 86, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&document_type=Supporting+%26+Related+Material", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039", "results": [{"value": 2008, "label": 2008, "count": 115, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2008", "selected": false}, {"value": 2009, "label": 2009, "count": 72, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2009", "selected": false}, {"value": 2012, "label": 2012, "count": 60, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2012", "selected": false}, {"value": 1998, "label": 1998, "count": 14, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=1998", "selected": false}, {"value": 1996, "label": 1996, "count": 13, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=1996", "selected": false}, {"value": 2014, "label": 2014, "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2014", "selected": false}, {"value": 1999, "label": 1999, "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=1999", "selected": false}, {"value": 2010, "label": 2010, "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2010", "selected": false}, {"value": 2000, "label": 2000, "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2000", "selected": false}, {"value": 1997, "label": 1997, "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=1997", "selected": false}, {"value": 1995, "label": 1995, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=1995", "selected": false}, {"value": 2006, "label": 2006, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2006", "selected": false}, {"value": 2007, "label": 2007, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2007", "selected": false}, {"value": 2003, "label": 2003, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2003", "selected": false}, {"value": 2005, "label": 2005, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2005", "selected": false}, {"value": 2011, "label": 2011, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2011", "selected": false}, {"value": 2013, "label": 2013, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&posted_year=2013", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&_facet=posted_month"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&_facet_date=last_modified"}], "next": "2009-12-04T05~3A00~3A00Z,FDA-1995-S-0039-0220", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-1995-S-0039&_next=2009-12-04T05~3A00~3A00Z%2CFDA-1995-S-0039-0220&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 85.32583806663752, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}